Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Base de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Compend Contin Educ Dent ; 42(3): 140-141, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-34010575

RESUMEN

Advancements in digital dentistry technology continue to change how dentists work. The recent onset of COVID-19 has presented new challenges to dentists by prompting renewed priorities such as providing patients with peace of mind, controlling and reducing contamination risks, and increasing treatment efficiency to boost productivity and profitability. Digital technologies such as intraoral scanners and in-office CAD/CAM systems are, in many ways, the ideal tools to use in meeting these new challenges, and thus dentists are turning to digital methods faster than ever before.


Asunto(s)
COVID-19 , Diseño Asistido por Computadora , Humanos , SARS-CoV-2
2.
Cell Stem Cell ; 27(6): 869-875.e4, 2020 12 03.
Artículo en Inglés | MEDLINE | ID: mdl-33259798

RESUMEN

Current smoking is associated with increased risk of severe COVID-19, but it is not clear how cigarette smoke (CS) exposure affects SARS-CoV-2 airway cell infection. We directly exposed air-liquid interface (ALI) cultures derived from primary human nonsmoker airway basal stem cells (ABSCs) to short term CS and then infected them with SARS-CoV-2. We found an increase in the number of infected airway cells after CS exposure with a lack of ABSC proliferation. Single-cell profiling of the cultures showed that the normal interferon response was reduced after CS exposure with infection. Treatment of CS-exposed ALI cultures with interferon ß-1 abrogated the viral infection, suggesting one potential mechanism for more severe viral infection. Our data show that acute CS exposure allows for more severe airway epithelial disease from SARS-CoV-2 by reducing the innate immune response and ABSC proliferation and has implications for disease spread and severity in people exposed to CS.


Asunto(s)
COVID-19/fisiopatología , Mucosa Respiratoria/fisiopatología , Fumar/efectos adversos , Células Madre/virología , COVID-19/genética , COVID-19/inmunología , COVID-19/terapia , Células Cultivadas , Regulación hacia Abajo , Humanos , Inmunidad Innata , Interferón beta/uso terapéutico , Gravedad del Paciente , Mucosa Respiratoria/virología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA